On August 18, 2015, nearly 30 HIV and social service providers in Peoria participated in an IPHA-sponsored training regarding Pre-exposure prophylaxis (PrEP) medication for HIV prevention, entitled “Project Ready, Set, PrEP!” The training was presented by Jim Pickett, AIDS Foundation of Chicago’s Director of Prevention Advocacy and Gay Men’s Health, and Sara Semelka, AIDS Foundation of Chicago's Female Condom Campaign Staff. The event was hosted by IPHA and Peoria’s Central Illinois Friends of PWA, Inc., and was held at UnityPoint Methodist Medical Center. The purpose of the training was to educate providers about Pre-Exposure Prophylaxis (PrEP) and what it means for HIV prevention and public health.
Pre-exposure prophylaxis (PrEP) is the daily use of anti-retroviral HIV medication by HIV-negative persons at substantial risk for HIV infection to prevent HIV infection. The medication (brand name Truvada) approved by the U.S. Public Health Service for PrEP contains two drugs (tenofovir and emtricitabine) that are used in combination with other medicines to treat HIV. When an individual is exposed to HIV through sex or injection drug use, these medicines reduce the likelihood that HIV will establish a permanent infection. The level of effectiveness is dependent upon medication adherence consistency. PrEP is recommended for use in combination with condoms and other prevention methods. For more information on Federal Guidelines for PrEP and recommended at-risk populations, please visit: http://www.cdc.gov/hiv/basics/prep.html
If your organization is interested in a “Project Ready, Set, PrEP!” training, please contact IPHA’s Jeffery Erdman at firstname.lastname@example.org or 217-522-5687.